You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 114 No. 11, November 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma

J. E. Kingston, J. L. Hungerford, S. A. Madreperla and P. N. Plowman
Department of Paediatric Oncology, St. Bartholomew's Hospital, London, England.

OBJECTIVE: To determine the visual anatomical results and survival after combined chemotherapy and whole eye radiotherapy for patients with bilateral Reese-Ellsworth group V retinoblastoma. SETTING: A national referral center for retinoblastoma. PATIENTS: Fourteen patients with bilateral Reese-Ellsworth group V retinoblastoma seen between March 1, 1989, and April 30, 1995, were treated. INTERVENTIONS: Patients were treated with chemotherapy (using carboplatin, etoposide, and vincristine) and whole eye radiotherapy (40-44 Gy in 20-22 equivalent fractions). A medical record review was performed to determine outcomes. MAIN OUTCOME MEASURES: Survival, eye preservation rate, and visual acuity. RESULTS: Two patients died, 1 from a primitive neuroectodermal tumor and the other from the meningeal spread of retinoblastoma. Four eyes were enucleated primarily because of severe disease at presentation. Of the remaining 20 eyes, 6 required enucleation. The disease recurred in 4 of those patients, and neovascular glaucoma developed in 2 patients. Of the 12 surviving children, 5 have a visual acuity better than l/60 in at least 1 eye. CONCLUSION: Although most of the treated group V eyes could be salvaged with chemotherapy plus radiotherapy, the resultant visual acuity was often poor.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Adverse Events of Chemotherapy for Retinoblastoma: What Are They? Do We Know?
Rizzuti et al.
Arch Ophthalmol 2008;126:862-865.
FULL TEXT  

Retinoblastoma: Review of Current Management
Chintagumpala et al.
The Oncologist 2007;12:1237-1246.
ABSTRACT | FULL TEXT  

Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor?
Gombos et al.
Br. J. Ophthalmol. 2006;90:1168-1172.
ABSTRACT | FULL TEXT  

Socioeconomic Impact of Modern Multidisciplinary Management of Retinoblastoma
Wilson et al.
Pediatrics 2006;118:e331-e336.
ABSTRACT | FULL TEXT  

Immunohistochemical detection of multidrug-resistant protein expression in retinoblastoma treated by primary enucleation.
Wilson et al.
IOVS 2006;47:1269-1273.
ABSTRACT | FULL TEXT  

Systemic carboplatin for retinoblastoma: change in tumour size over time
Abramson et al.
Br. J. Ophthalmol. 2005;89:1616-1619.
ABSTRACT | FULL TEXT  

Long-term Visual Outcome Following Chemoreduction for Retinoblastoma
Demirci et al.
Arch Ophthalmol 2005;123:1525-1530.
ABSTRACT | FULL TEXT  

Intraocular Surgery After Treatment of Germline Retinoblastoma
Moshfeghi et al.
Arch Ophthalmol 2005;123:1008-1012.
FULL TEXT  

Macular Retinoblastoma Managed With Chemoreduction: Analysis of Tumor Control With or Without Adjuvant Thermotherapy in 68 Tumors
Shields et al.
Arch Ophthalmol 2005;123:765-773.
ABSTRACT | FULL TEXT  

Pharmacokinetics of Systemic Versus Focal Carboplatin Chemotherapy in the Rabbit Eye: Possible Implication in the Treatment of Retinoblastoma
Hayden et al.
IOVS 2004;45:3644-3649.
ABSTRACT | FULL TEXT  

Outcome Following Initial External Beam Radiotherapy in Patients With Reese-Ellsworth Group Vb Retinoblastoma
Abramson et al.
Arch Ophthalmol 2004;122:1316-1323.
ABSTRACT | FULL TEXT  

Visual Fields in Retinoblastoma Survivors
Abramson et al.
Arch Ophthalmol 2004;122:1324-1330.
ABSTRACT | FULL TEXT  

Practical Approach to Management of Retinoblastoma
Shields et al.
Arch Ophthalmol 2004;122:729-735.
ABSTRACT | FULL TEXT  

External Beam Radiation "Salvage" Therapy in Transgenic Murine Retinoblastoma
Sobrin et al.
Arch Ophthalmol 2004;122:251-257.
ABSTRACT | FULL TEXT  

Eye-Preservation Treatment of Retinoblastoma with Vitreous Seeding
Kaneko and Suzuki
Jpn J Clin Oncol 2003;33:601-607.
ABSTRACT | FULL TEXT  

Development of New Retinoblastomas After 6 Cycles of Chemoreduction for Retinoblastoma in 162 Eyes of 106 Consecutive Patients
Shields et al.
Arch Ophthalmol 2003;121:1571-1576.
ABSTRACT | FULL TEXT  

Globe conserving treatment of the only eye in bilateral retinoblastoma
Lee et al.
Br. J. Ophthalmol. 2003;87:1374-1380.
ABSTRACT | FULL TEXT  

Ocular Motility Changes After Subtenon Carboplatin Chemotherapy for Retinoblastoma
Mulvihill et al.
Arch Ophthalmol 2003;121:1120-1124.
ABSTRACT | FULL TEXT  

Histopathologic Findings in Eyes With Retinoblastoma Treated Only With Chemoreduction
Demirci et al.
Arch Ophthalmol 2003;121:1125-1131.
ABSTRACT | FULL TEXT  

Treatment of Intraocular Retinoblastoma With Vincristine and Carboplatin
Rodriguez-Galindo et al.
JCO 2003;21:2019-2025.
ABSTRACT | FULL TEXT  

Neoadjuvant chemotherapy for extensive unilateral retinoblastoma
Bellaton et al.
Br. J. Ophthalmol. 2003;87:327-329.
ABSTRACT | FULL TEXT  

Chemoreduction for Unilateral Retinoblastoma
Shields et al.
Arch Ophthalmol 2002;120:1653-1658.
ABSTRACT | FULL TEXT  

Postenucleation Adjuvant Therapy in High-Risk Retinoblastoma
Honavar et al.
Arch Ophthalmol 2002;120:923-931.
ABSTRACT | FULL TEXT  

Factors Predictive of Recurrence of Retinal Tumors, Vitreous Seeds, and Subretinal Seeds Following Chemoreduction for Retinoblastoma
Shields et al.
Arch Ophthalmol 2002;120:460-464.
ABSTRACT | FULL TEXT  

Hyperfractionated External Beam Radiation Therapy in the Treatment of Murine Transgenic Retinoblastoma
Hayden et al.
Arch Ophthalmol 2002;120:353-359.
ABSTRACT | FULL TEXT  

Retinoblastoma treated with primary chemotherapy alone: the significance of tumour size, location, and age
Gombos et al.
Br. J. Ophthalmol. 2002;86:80-83.
ABSTRACT | FULL TEXT  

First-Line Chemotherapy With Local Treatment Can Prevent External-Beam Irradiation and Enucleation in Low-Stage Intraocular Retinoblastoma
Beck et al.
JCO 2000;18:2881-2887.
ABSTRACT | FULL TEXT  

Chemoreduction and Local Ophthalmic Therapy for Intraocular Retinoblastoma
Friedman et al.
JCO 2000;18:12-12.
ABSTRACT | FULL TEXT  

Obtaining Maximal Optic Nerve Length During Enucleation Procedures
Coats et al.
Arch Ophthalmol 2000;118:70-73.
ABSTRACT | FULL TEXT  

Importance of early diagnosis of retinoblastoma
SHIELDS
Br. J. Ophthalmol. 1999;83:1315-1316.
FULL TEXT  

Thermotherapy for Retinoblastoma
Shields et al.
Arch Ophthalmol 1999;117:885-893.
ABSTRACT | FULL TEXT  

The Outcome of Chemoreduction Treatment in Patients With Reese-Ellsworth Group V Retinoblastoma
Gunduz et al.
Arch Ophthalmol 1998;116:1613-1617.
ABSTRACT | FULL TEXT  

Intraocular Concentrations of Chemotherapeutic Agents After Systemic or Local Administration
Mendelsohn et al.
Arch Ophthalmol 1998;116:1209-1212.
ABSTRACT | FULL TEXT  

Clinicopathologic Features of Retinoblastoma After Primary Chemoreduction
Bechrakis et al.
Arch Ophthalmol 1998;116:887-893.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.